🔎 Trials Near Me

Akèy › Gliyòm › Texas › Dallas

Etid klinik pou Gliyòm nan Dallas, TX

6 etid pou Gliyòm ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Ap rekriteFaz 1/2
  • Medical City Dallas Hospital, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
12 Months – 21 Years · Tout sèks · Mizajou Oct 1, 2026 · NCT05099003

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Ap rekriteFaz 1/2
  • The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
Jiska laj 25 · Tout sèks · Mizajou Sep 25, 2026 · NCT04094610

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Ap rekriteFaz 3
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

Ap rekriteFaz 1
  • University Of Texas Southwestern Medical Center, Dallas
Laj 1 a 25 · Tout sèks · Mizajou Aug 18, 2026 · NCT04485559

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Ap rekriteFaz 2
  • Baylor Scott & White Research Institute, Dallas
Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Ap rekriteFaz 1/2
  • UT Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Mar 26, 2025 · NCT01906385

Etid Gliyòm nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.